a n u l r e p o t 2 0 4 tepnel life sciences is targeting key growth areas within the research products and services molecular diagnostics markets kits for dna purification monoclonal antibody custom development analytical chemistry bioanalysis microbiological testing pharma biotech healthcare industries food safety including allergens gmo s nucleic acid analysis diagnostic hla typing detection identity mutation human in vitro genetic screening approach allows it to maximise cross selling opportunities its customers pharmaceutical biotechnology biomedical highlights 1 chairman statement operational review financial 7 directors report 9 corporate governance statements 11 of independent auditors 14 consolidated profit & loss account 15 balance sheet 16 company 17 cash flow 18 accounting policies 19 notes forming part 21 reconciliation 12 months results 32
